We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+13.55%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$58.8B
AUM Growth
+$7.51B
Cap. Flow
+$1.9B
Cap. Flow %
3.23%
Top 10 Hldgs %
34.73%
Holding
979
New
37
Increased
681
Reduced
201
Closed
28

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$154M
2
SPOT icon
Spotify
SPOT
+$132M
3
NVDA icon
NVIDIA
NVDA
+$124M
4
MSFT icon
Microsoft
MSFT
+$107M
5
META icon
Meta Platforms (Facebook)
META
+$71.3M

Sector Composition

Rank Sector Weight
1 Technology 32.3%
2 Healthcare 12.75%
3 Consumer Discretionary 11.56%
4 Financials 10.82%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHKP icon
626
Check Point Software Technologies
CHKP
$13.3B
$8.82M 0.02%
39,850
+1,848
+5% +$407K
PKG icon
627
Packaging Corp of America
PKG
$22.7B
$8.78M 0.01%
46,617
+1,813
+4% +$343K
WPC icon
628
W.P. Carey
WPC
$17.1B
$8.77M 0.01%
142,932
+16,975
+13% +$1.05M
ICLR icon
629
Icon
ICLR
$12.8B
$8.61M 0.01%
59,211
+3,165
+6% +$449K
TSN icon
630
Tyson Foods
TSN
$20.2B
$8.57M 0.01%
153,171
+20,708
+16% +$1.19M
AXSM icon
631
Axsome Therapeutics
AXSM
$12.4B
$8.55M 0.01%
81,916
+17,962
+28% +$1.9M
CAAP icon
632
Corporacion America
CAAP
$4.11B
$8.54M 0.01%
421,700
+1,400
+0.3% +$27.6K
ALLY icon
633
Ally Financial
ALLY
$13.1B
$8.47M 0.01%
217,390
+9,211
+4% +$319K
EPAM icon
634
EPAM Systems
EPAM
$4.69B
$8.43M 0.01%
47,655
+5,824
+14% +$974K
LTC
635
LTC Properties
LTC
$2.16B
$8.42M 0.01%
243,272
+1,493
+0.6% +$52.5K
SSNC icon
636
SS&C Technologies
SSNC
$17.8B
$8.39M 0.01%
101,342
+5,593
+6% +$440K
FUTU icon
637
Futu Holdings
FUTU
$13.9B
$8.35M 0.01%
68,382
-3,115
-4% -$319K
GPCR icon
638
Structure Therapeutics
GPCR
$3.49B
$8.33M 0.01%
401,624
+152,725
+61% +$3.36M
GEHC icon
639
GE HealthCare
GEHC
$27.6B
$8.3M 0.01%
112,065
+7,791
+7% +$542K
FNF icon
640
Fidelity National Financial
FNF
$13.9B
$8.29M 0.01%
147,842
+8,363
+6% +$489K
RPRX icon
641
Royalty Pharma
RPRX
$26.1B
$8.21M 0.01%
228,746
+14,886
+7% +$493K
MREO
642
Mereo BioPharma
MREO
$45.9M
$8.21M 0.01%
3,028,872
+840,518
+38% +$2.03M
INCY icon
643
Incyte
INCY
$23.5B
$8.08M 0.01%
118,677
-10,298
-8% -$652K
CRNX icon
644
Crinetics Pharmaceuticals
CRNX
$8.86B
$8.06M 0.01%
280,347
+72,288
+35% +$2.23M
UAL icon
645
United Airlines
UAL
$38.4B
$8.04M 0.01%
100,942
+4,267
+4% +$314K
CHEF icon
646
Chefs' Warehouse
CHEF
$3.87B
$8.03M 0.01%
+125,887
New +$7.48M
CG icon
647
Carlyle Group
CG
$16.3B
$7.96M 0.01%
154,893
+14,851
+11% +$640K
RNAM
648
DELISTED
Avidity Biosciences
RNAM
$7.95M 0.01%
279,828
WSM icon
649
Williams-Sonoma
WSM
$26.7B
$7.92M 0.01%
48,844
+17,844
+58% +$2.8M
ACHC icon
650
Acadia Healthcare
ACHC
$3.17B
$7.9M 0.01%
348,117
+239,595
+221% +$5.68M

Similar funds

Aberdeen Group's Q2 2025 Portfolio in Review

As of Q2 2025, Aberdeen Group held 979 positions worth $58.8B, up 15% from $51.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aberdeen Group deployed $1.9B of net new capital in Q2 2025, opening 37 new positions and adding to 681 existing holdings. Its largest new stake was On Holding: 756,875 shares worth $39.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Southern Copper, an estimated $61.4M trimmed.

  • Aberdeen Group's largest Q2 2025 buy was On Holding: 756,875 shares worth $39.4M.
  • Aberdeen Group added most to Apple in Q2 2025, an estimated $154M increase.
  • Aberdeen Group's biggest Q2 2025 reduction was Southern Copper, cutting an estimated $61.4M.
  • Aberdeen Group fully exited Globant in Q2 2025, selling an estimated $60.5M.
  • Aberdeen Group's ten largest holdings make up 35% of its $58.8B portfolio in Q2 2025.
  • Aberdeen Group opened 37 new positions and closed 28 in Q2 2025.
  • Aberdeen Group's portfolio value rose 15% quarter-over-quarter to $58.8B.

Based on Aberdeen Group's 13F filing for Q2 2025, filed 24 Jul 2025.